Emergency Task Force (ETF) documents
Submitted by Anonymous (not verified) on 2 May 2025 - 17:19
Emergency Task Force (ETF) documents
PRAC-ETF considerations on the use of Ixchiq live attenuated virus vaccine against chikungunya
Submitted by Anonymous (not verified) on 2 May 2025 - 17:14
PRAC-ETF considerations on the use of Ixchiq live attenuated virus vaccine against chikungunya
Organisation chart: Advisory functions
Submitted by Anonymous (not verified) on 2 May 2025 - 16:00
Organisation chart: Advisory functions
Human medicines European public assessment report (EPAR): Capecitabine Medac, capecitabine, Date of authorisation: 19/11/2012, Revision: 14, Status: Authorised
Submitted by Anonymous (not verified) on 2 May 2025 - 15:50
Human medicines European public assessment report (EPAR): Capecitabine Medac, capecitabine, Date of authorisation: 19/11/2012, Revision: 14, Status: Authorised
Human medicines European public assessment report (EPAR): Xeloda, capecitabine, Date of authorisation: 02/02/2001, Revision: 31, Status: Authorised
Submitted by Anonymous (not verified) on 2 May 2025 - 15:48
Human medicines European public assessment report (EPAR): Xeloda, capecitabine, Date of authorisation: 02/02/2001, Revision: 31, Status: Authorised
Human medicines European public assessment report (EPAR): Eptifibatide Accord, eptifibatide, Date of authorisation: 11/01/2016, Revision: 8, Status: Authorised
Submitted by Anonymous (not verified) on 2 May 2025 - 15:42
Human medicines European public assessment report (EPAR): Eptifibatide Accord, eptifibatide, Date of authorisation: 11/01/2016, Revision: 8, Status: Authorised
Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)
Submitted by Anonymous (not verified) on 2 May 2025 - 14:52
Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)
Human medicines European public assessment report (EPAR): Alprolix, eftrenonacog alfa, Date of authorisation: 12/05/2016, Revision: 11, Status: Authorised
Submitted by Anonymous (not verified) on 2 May 2025 - 14:46
Human medicines European public assessment report (EPAR): Alprolix, eftrenonacog alfa, Date of authorisation: 12/05/2016, Revision: 11, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Pirsue, pirlimycin, Date of authorisation: 29/01/2001, Status: Withdrawn
Submitted by Anonymous (not verified) on 2 May 2025 - 14:37
Veterinary medicines European public assessment report (EPAR): Pirsue, pirlimycin, Date of authorisation: 29/01/2001, Status: Withdrawn
Agenda of the HMPC meeting 5-7 May 2025
Submitted by Anonymous (not verified) on 2 May 2025 - 13:04
Agenda of the HMPC meeting 5-7 May 2025